A Phase 1, Open Labeled, Fixed Sequence Study To Estimate The Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 01 Nov 2014
At a glance
- Drugs Metformin; Tofacitinib
- Indications Asthma; Diabetes mellitus; Inflammatory bowel diseases; Irritable bowel syndrome; Psoriasis; Renal transplant rejection; Rheumatic disorders
- Focus Pharmacokinetics
- Sponsors Pfizer
- 17 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Aug 2011 New trial record